Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symporter for Squamous Cell Cancer of the Head and Neck Radiovirotherapy

Human Gene Therapy - United States
doi 10.1089/hum.2011.128
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Mary Ann Liebert Inc

Related search

Image-Guided Radiovirotherapy for Multiple Myeloma Using a Recombinant Measles Virus Expressing the Thyroidal Sodium Iodide Symporter

Blood
BiochemistryImmunologyCell BiologyHematology
2004English

Treatment of Medulloblastoma Using an Oncolytic Measles Virus Encoding the Thyroidal Sodium Iodide Symporter Shows Enhanced Efficacy With Radioiodine

BMC Cancer
Cancer ResearchOncologyGenetics
2012English

Chemovirotherapy for Head and Neck Squamous Cell Carcinoma With EGFR-targeted and CD/UPRT-armed Oncolytic Measles Virus

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2011English

Oncolytic Vaccinia Virus as a Vector for Therapeutic Sodium Iodide Symporter Gene Therapy in Prostate Cancer

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2016English

Human Papilloma Virus in Head and Neck Squamous Cell Cancer.

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2011English

Squamous Cell Head and Neck Cancer

2005English

Preclinical Efficacy of the Oncolytic Measles Virus Expressing the Sodium Iodide Symporter in Iodine Non-Avid Anaplastic Thyroid Cancer: A Novel Therapeutic Agent Allowing Noninvasive Imaging and Radioiodine Therapy

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2012English

Homology Modelling of Sodium Iodide Symporter

Biophysical Journal
Biophysics
2018English

Monoclonal Antibodies Against the Human Sodium Iodide Symporter: Utility for Immunocytochemistry of Thyroid Cancer

Journal of Endocrinology
EndocrinologyMetabolismDiabetes
1999English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy